Source: |
Type: |
(Also known as Hsp32 and HMOX1) HO-1 is the common abbreviation for the protein (heme oxygenase‑1) produced by the HMOX1 gene. HO-1 is an enzyme that plays a crucial role in various cellular processes, including the breakdown of heme, a toxic molecule. Research has shown that HO-1 is involved in the development and progression of cancer. -widely regarded as having antioxidant and cytoprotective effects -The overall activity of HO‑1 helps to reduce the pro‐oxidant load (by degrading free heme, a pro‑oxidant) and to generate molecules (like bilirubin) that can protect cells from oxidative damage Studies have found that HO-1 is overexpressed in various types of cancer, including lung, breast, colon, and prostate cancer. The overexpression of HO-1 in cancer cells can contribute to their survival and proliferation by: Reducing oxidative stress and inflammation Promoting angiogenesis (the formation of new blood vessels) Inhibiting apoptosis (programmed cell death) Enhancing cell migration and invasion When HO-1 is at a normal level, it mainly exerts an antioxidant effect, and when it is excessively elevated, it causes an accumulation of iron ions. A proper cellular level of HMOX1 plays an antioxidative function to protect cells from ROS toxicity. However, its overexpression has pro-oxidant effects to induce ferroptosis of cells, which is dependent on intracellular iron accumulation and increased ROS content upon excessive activation of HMOX1. -Curcumin Activates the Nrf2 pathway leading to HO‑1 induction; known for its anti‑inflammatory and antioxidant effects. -Resveratrol Induces HO‑1 via activation of SIRT1/Nrf2 signaling; exhibits antioxidant and cardioprotective properties. -Quercetin Activates Nrf2 and related antioxidant pathways; contributes to anti‑oxidative and anti‑inflammatory responses. -EGCG Promotes HO‑1 expression through activation of the Nrf2/ARE pathway; also exhibits anti‑inflammatory and anticancer properties. -Sulforaphane One of the most potent natural HO‑1 inducers; triggers Nrf2 nuclear translocation and upregulates a battery of phase II detoxifying enzymes. -Luteolin Induces HO‑1 via Nrf2 activation; may also exert anti‑inflammatory and neuroprotective effects in various cell models. -Apigenin Has been reported to induce HO‑1 expression partly via the MAPK and Nrf2 pathways; also known for anti‑inflammatory and anticancer activities. |
3453- | 5-ALA, | The heme precursor 5-aminolevulinic acid disrupts the Warburg effect in tumor cells and induces caspase-dependent apoptosis |
- | in-vitro, | Lung, | A549 |
256- | AL, | doxoR, | Allicin Overcomes Doxorubicin Resistance of Breast Cancer Cells by Targeting the Nrf2 Pathway |
- | in-vitro, | BC, | MCF-7 | - | in-vitro, | BC, | MDA-MB-231 |
2657- | AL, | Allicin pharmacology: Common molecular mechanisms against neuroinflammation and cardiovascular diseases |
- | Review, | CardioV, | NA | - | Review, | AD, | NA |
3441- | ALA, | α-Lipoic Acid Maintains Brain Glucose Metabolism via BDNF/TrkB/HIF-1α Signaling Pathway in P301S Mice |
- | in-vivo, | AD, | NA |
3456- | ALA, | Renal-Protective Roles of Lipoic Acid in Kidney Disease |
- | Review, | NA, | NA |
3271- | ALA, | Decrypting the potential role of α-lipoic acid in Alzheimer's disease |
- | Review, | AD, | NA |
3547- | ALA, | Potential Therapeutic Effects of Lipoic Acid on Memory Deficits Related to Aging and Neurodegeneration |
- | Review, | AD, | NA | - | Review, | Park, | NA |
1235- | ALA, | Cisplatin, | α-Lipoic acid prevents against cisplatin cytotoxicity via activation of the NRF2/HO-1 antioxidant pathway |
- | in-vitro, | Nor, | HEI-OC1 | - | ex-vivo, | NA, | NA |
4280- | Api, | Protective effects of apigenin in neurodegeneration: An update on the potential mechanisms |
- | Review, | AD, | NA | - | Review, | Park, | NA |
4278- | ART/DHA, | Artemisinin Ameliorates the Neurotoxic Effect of 3-Nitropropionic Acid: A Possible Involvement of the ERK/BDNF/Nrf2/HO-1 Signaling Pathway |
- | in-vivo, | NA, | NA |
1357- | Ash, | Cytotoxicity of withaferin A in glioblastomas involves induction of an oxidative stress-mediated heat shock response while altering Akt/mTOR and MAPK signaling pathways |
- | in-vitro, | GBM, | U87MG | - | in-vitro, | GBM, | U251 | - | in-vitro, | GBM, | GL26 |
3687- | Ash, | Role of Withaferin A and Its Derivatives in the Management of Alzheimer’s Disease: Recent Trends and Future Perspectives |
- | Review, | AD, | NA |
3156- | Ash, | Withaferin A: From ayurvedic folk medicine to preclinical anti-cancer drug |
- | Review, | Var, | NA |
3160- | Ash, | Withaferin A: A Pleiotropic Anticancer Agent from the Indian Medicinal Plant Withania somnifera (L.) Dunal |
- | Review, | Var, | NA |
3161- | Ash, | Withaferin A inhibits ferroptosis and protects against intracerebral hemorrhage |
- | in-vivo, | Stroke, | NA |
3163- | Ash, | Rad, | Withaferin A, a steroidal lactone, selectively protects normal lymphocytes against ionizing radiation induced apoptosis and genotoxicity via activation of ERK/Nrf-2/HO-1 axis |
3173- | Ash, | Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma |
- | in-vitro, | neuroblastoma, | NA |
3166- | Ash, | Exploring the Multifaceted Therapeutic Potential of Withaferin A and Its Derivatives |
- | Review, | Var, | NA |
2623- | Ba, | Activation of the Nrf2/HO-1 signaling pathway contributes to the protective effects of baicalein against oxidative stress-induced DNA damage and apoptosis in HEI193 Schwann cells |
- | in-vitro, | Nor, | HEI193 |
2624- | Ba, | Baicalein inhibition of hydrogen peroxide-induced apoptosis via ROS-dependent heme oxygenase 1 gene expression |
- | in-vitro, | Nor, | RAW264.7 |
2625- | Ba, | LT, | Baicalein and luteolin inhibit ischemia/reperfusion-induced ferroptosis in rat cardiomyocyte |
- | in-vivo, | Stroke, | NA |
2627- | Ba, | Cisplatin, | Baicalein, a Bioflavonoid, Prevents Cisplatin-Induced Acute Kidney Injury by Up-Regulating Antioxidant Defenses and Down-Regulating the MAPKs and NF-κB Pathways |
2296- | Ba, | The most recent progress of baicalein in its anti-neoplastic effects and mechanisms |
- | Review, | Var, | NA |
1390- | BBR, | Rad, | Berberine Inhibited Radioresistant Effects and Enhanced Anti-Tumor Effects in the Irradiated-Human Prostate Cancer Cells |
- | in-vitro, | Pca, | PC3 |
1392- | BBR, | Based on network pharmacology and experimental validation, berberine can inhibit the progression of gastric cancer by modulating oxidative stress |
- | in-vitro, | GC, | AGS | - | in-vitro, | GC, | MKN45 |
1380- | BBR, | doxoR, | treatment with ROS scavenger N-acetylcysteine (NAC) and JNK inhibitor SP600125 could partially attenuate apoptosis and DNA damage triggered by DCZ0358. |
- | in-vivo, | Nor, | NA |
3678- | BBR, | Network pharmacology study on the mechanism of berberine in Alzheimer’s disease model |
- | Review, | AD, | NA |
2749- | BetA, | Anti-Inflammatory Activities of Betulinic Acid: A Review |
- | Review, | Nor, | NA |
2756- | BetA, | Betulinic acid inhibits growth of hepatoma cells through activating the NCOA4-mediated ferritinophagy pathway |
- | in-vitro, | HCC, | HUH7 | - | in-vitro, | HCC, | H1299 |
2757- | BetA, | Betulinic Acid Inhibits Glioma Progression by Inducing Ferroptosis Through the PI3K/Akt and NRF2/HO-1 Pathways |
- | in-vitro, | GBM, | U251 |
2758- | BetA, | Betulinic Acid Attenuates Oxidative Stress in the Thymus Induced by Acute Exposure to T-2 Toxin via Regulation of the MAPK/Nrf2 Signaling Pathway |
- | in-vivo, | Nor, | NA |
3513- | Bor, | Boric Acid Activation of eIF2α and Nrf2 Is PERK Dependent: a Mechanism that Explains How Boron Prevents DNA Damage and Enhances Antioxidant Status |
- | in-vitro, | Pca, | DU145 | - | in-vitro, | Nor, | MEF |
3510- | Bor, | Boron Affects the Development of the Kidney Through Modulation of Apoptosis, Antioxidant Capacity, and Nrf2 Pathway in the African Ostrich Chicks |
- | in-vivo, | Nor, | NA |
3524- | Bor, | Boric Acid Alleviates Lipopolysaccharide-Induced Acute Lung Injury in Mice |
1425- | Bos, | Protective Effect of Boswellic Acids against Doxorubicin-Induced Hepatotoxicity: Impact on Nrf2/HO-1 Defense Pathway |
- | in-vivo, | Nor, | NA |
2775- | Bos, | The journey of boswellic acids from synthesis to pharmacological activities |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | PSA, | NA |
2772- | Bos, | Mechanistic role of boswellic acids in Alzheimer’s disease: Emphasis on anti-inflammatory properties |
- | Review, | AD, | NA |
4263- | CA, | Neuroprotective Effects of Carnosic Acid: Insight into Its Mechanisms of Action |
- | Review, | AD, | NA |
4264- | CA, | HO-1_Pathway">Carnosic Acid Mitigates Depression-Like Behavior in Ovariectomized Mice via Activation of Nrf2HO-1 Pathway |
- | in-vivo, | NA, | NA |
2394- | CAP, | Capsaicin acts as a novel NRF2 agonist to suppress ethanol induced gastric mucosa oxidative damage by directly disrupting the KEAP1-NRF2 interaction |
- | in-vitro, | Nor, | GES-1 |
2392- | Cela, | The role of natural products targeting macrophage polarization in sepsis-induced lung injury |
- | Review, | Sepsis, | NA |
2591- | CHr, | doxoR, | Chrysin enhances sensitivity of BEL-7402/ADM cells to doxorubicin by suppressing PI3K/Akt/Nrf2 and ERK/Nrf2 pathway |
- | in-vitro, | HCC, | Bel-7402 |
2590- | CHr, | Chrysin suppresses proliferation, migration, and invasion in glioblastoma cell lines via mediating the ERK/Nrf2 signaling pathway |
- | in-vitro, | GBM, | T98G | - | in-vitro, | GBM, | U251 | - | in-vitro, | GBM, | U87MG |
2794- | CHr, | An updated review on the versatile role of chrysin in neurological diseases: Chemistry, pharmacology, and drug delivery approaches |
- | Review, | Park, | NA | - | Review, | Stroke, | NA |
2807- | CHr, | Evidence-based mechanistic role of chrysin towards protection of cardiac hypertrophy and fibrosis in rats |
- | in-vivo, | Nor, | NA |
2785- | CHr, | Emerging cellular and molecular mechanisms underlying anticancer indications of chrysin |
- | Review, | Var, | NA |
1571- | Cu, | Copper in cancer: From pathogenesis to therapy |
- | Review, | NA, | NA |
1485- | CUR, | Chemo, | Rad, | Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs |
- | Review, | Var, | NA |
1410- | CUR, | Curcumin induces ferroptosis and apoptosis in osteosarcoma cells by regulating Nrf2/GPX4 signaling pathway |
- | vitro+vivo, | OS, | MG63 |
414- | CUR, | Transcriptome Investigation and In Vitro Verification of Curcumin-Induced HO-1 as a Feature of Ferroptosis in Breast Cancer Cells |
- | in-vitro, | BC, | MCF-7 | - | in-vitro, | BC, | MDA-MB-231 |
2821- | CUR, | Antioxidant curcumin induces oxidative stress to kill tumor cells (Review) |
- | Review, | Var, | NA |
2819- | CUR, | Chemo, | Curcumin as a hepatoprotective agent against chemotherapy-induced liver injury |
- | Review, | Var, | NA |
2688- | CUR, | Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs |
- | Review, | Var, | NA | - | Review, | AD, | NA |
3794- | CUR, | Curcumin hybrid molecules for the treatment of Alzheimer's disease: Structure and pharmacological activities |
- | Review, | AD, | NA |
3795- | CUR, | Curcumin: A Golden Approach to Healthy Aging: A Systematic Review of the Evidence |
- | Review, | AD, | NA |
3574- | CUR, | The effect of curcumin (turmeric) on Alzheimer's disease: An overview |
- | Review, | AD, | NA |
3576- | CUR, | Protective Effects of Indian Spice Curcumin Against Amyloid-β in Alzheimer's Disease |
- | Review, | AD, | NA |
1847- | dietFMD, | VitC, | Synergistic effect of fasting-mimicking diet and vitamin C against KRAS mutated cancers |
- | in-vitro, | PC, | PANC1 |
1846- | dietFMD, | VitC, | A fasting-mimicking diet and vitamin C: turning anti-aging strategies against cancer |
- | Study, | Var, | NA |
1859- | dietFMD, | Chemo, | Fasting-Mimicking Diet Reduces HO-1 to Promote T Cell-Mediated Tumor Cytotoxicity |
- | in-vitro, | BC, | 4T1 | - | in-vivo, | Melanoma, | B16-BL6 |
1863- | dietFMD, | Chemo, | Effect of fasting on cancer: A narrative review of scientific evidence |
- | Review, | Var, | NA |
2272- | dietMet, | Methionine restriction - Association with redox homeostasis and implications on aging and diseases |
- | Review, | Nor, | NA |
1626- | dietSTF, | dietFMD, | When less may be more: calorie restriction and response to cancer therapy |
- | Review, | Var, | NA |
1621- | EA, | The multifaceted mechanisms of ellagic acid in the treatment of tumors: State-of-the-art |
- | Review, | Var, | NA |
1605- | EA, | Ellagic Acid and Cancer Hallmarks: Insights from Experimental Evidence |
- | Review, | Var, | NA |
642- | EGCG, | Prooxidant Effects of Epigallocatechin-3-Gallate in Health Benefits and Potential Adverse Effect |
1974- | EGCG, | Protective Effect of Epigallocatechin-3-Gallate in Hydrogen Peroxide-Induced Oxidative Damage in Chicken Lymphocytes |
- | in-vitro, | Nor, | NA |
3211- | EGCG, | Antioxidation Function of EGCG by Activating Nrf2/HO-1 Pathway in Mice with Coronary Heart Disease |
- | in-vivo, | NA, | NA |
3214- | EGCG, | EGCG-induced selective death of cancer cells through autophagy-dependent regulation of the p62-mediated antioxidant survival pathway |
- | in-vitro, | Nor, | MRC-5 | - | in-vitro, | Cerv, | HeLa | - | in-vitro, | Nor, | HEK293 | - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | CRC, | HCT116 |
3215- | EGCG, | Epigallocatechin gallate modulates ferroptosis through downregulation of tsRNA-13502 in non-small cell lung cancer |
- | in-vitro, | NSCLC, | A549 | - | in-vitro, | NSCLC, | H1299 |
3712- | FA, | Ferulic Acid: A Hope for Alzheimer’s Disease Therapy from Plants |
- | Review, | AD, | NA |
3714- | FA, | Recent Advances in the Neuroprotective Properties of Ferulic Acid in Alzheimer's Disease: A Narrative Review |
- | Review, | AD, | NA |
3780- | FA, | Ferulic Acid: A Natural Antioxidant with Application Towards Neuroprotection Against Alzheimer’s Disease |
- | Review, | AD, | NA |
3779- | FA, | A review on ferulic acid and analogs based scaffolds for the management of Alzheimer’s disease |
- | Review, | AD, | NA |
3778- | FA, | Recent Advances in the Neuroprotective Properties of Ferulic Acid in Alzheimer’s Disease: A Narrative Review |
- | Review, | AD, | NA |
2845- | FIS, | Fisetin: A bioactive phytochemical with potential for cancer prevention and pharmacotherapy |
- | Review, | Var, | NA |
2858- | FIS, | Fisetin inhibits cell migration via inducing HO-1 and reducing MMPs expression in breast cancer cell lines |
- | in-vitro, | BC, | 4T1 |
2861- | FIS, | The neuroprotective effects of fisetin, a natural flavonoid in neurodegenerative diseases: Focus on the role of oxidative stress |
- | Review, | Nor, | NA | - | Review, | Stroke, | NA | - | Review, | Park, | NA |
2825- | FIS, | Exploring the molecular targets of dietary flavonoid fisetin in cancer |
- | Review, | Var, | NA |
2829- | FIS, | Fisetin: An anticancer perspective |
- | Review, | Var, | NA |
2830- | FIS, | Biological effects and mechanisms of fisetin in cancer: a promising anti-cancer agent |
- | Review, | Var, | NA |
1005- | GI, | Ginger Constituent 6-Shogaol Inhibits Inflammation- and Angiogenesis-Related Cell Functions in Primary Human Endothelial Cells |
- | vitro+vivo, | Nor, | HUVECs |
834- | Gra, | Anticancer Properties of Graviola (Annona muricata): A Comprehensive Mechanistic Review |
- | Review, | NA, | NA |
2508- | H2, | Molecular hydrogen is a promising therapeutic agent for pulmonary disease |
- | Review, | Var, | NA | - | Review, | Sepsis, | NA |
2521- | H2, | Oxyhydrogen Gas: A Promising Therapeutic Approach for Lung, Breast and Colorectal Cancer |
- | Review, | CRC, | NA | - | Review, | Lung, | NA | - | Review, | BC, | NA |
2514- | H2, | Hydrogen: A Novel Option in Human Disease Treatment |
- | Review, | NA, | NA |
2516- | H2, | Hydrogen Gas in Cancer Treatment |
- | Review, | Var, | NA |
3787- | H2, | Hydrogen, a Novel Therapeutic Molecule, Regulates Oxidative Stress, Inflammation, and Apoptosis |
- | Review, | AD, | NA |
3773- | H2, | Role and mechanism of molecular hydrogen in the treatment of Parkinson’s diseases |
- | Review, | Park, | NA |
3770- | H2, | Role of Molecular Hydrogen in Ageing and Ageing-Related Diseases |
- | Review, | AD, | NA | - | Review, | Park, | NA |
1633- | HCA, | Hydroxycitric Acid Alleviated Lung Ischemia-Reperfusion Injury by Inhibiting Oxidative Stress and Ferroptosis through the Hif-1α Pathway |
- | in-vivo, | NA, | NA | - | in-vitro, | Nor, | HUVECs |
2080- | HNK, | Honokiol Induces Ferroptosis by Upregulating HMOX1 in Acute Myeloid Leukemia Cells |
- | in-vitro, | AML, | THP1 | - | in-vitro, | AML, | U937 | - | in-vitro, | AML, | SK-HEP-1 |
2894- | HNK, | Pharmacological features, health benefits and clinical implications of honokiol |
- | Review, | Var, | NA | - | Review, | AD, | NA |
2868- | HNK, | Honokiol: A review of its pharmacological potential and therapeutic insights |
- | Review, | Var, | NA | - | Review, | Sepsis, | NA |
2870- | HNK, | Honokiol attenuates oxidative stress and vascular calcification via the upregulation of heme oxygenase-1 in chronic kidney disease |
- | in-vitro, | CKD, | NA |
2873- | HNK, | Honokiol Alleviates Oxidative Stress-Induced Neurotoxicity via Activation of Nrf2 |
- | in-vitro, | Nor, | PC12 |
2871- | HNK, | Antihyperalgesic Properties of Honokiol in Inflammatory Pain Models by Targeting of NF-κB and Nrf2 Signaling |
- | in-vivo, | Nor, | NA |
1921- | JG, | Juglone induces ferroptotic effect on hepatocellular carcinoma and pan-cancer via the FOSL1-HMOX1 axis |
- | in-vitro, | PC, | NA | - | vitro+vivo, | PC, | NA |
2915- | LT, | Luteolin promotes apoptotic cell death via upregulation of Nrf2 expression by DNA demethylase and the interaction of Nrf2 with p53 in human colon cancer cells |
- | in-vitro, | Colon, | HT29 | - | in-vitro, | CRC, | SNU-407 | - | in-vitro, | Nor, | FHC |
2919- | LT, | Luteolin as a potential therapeutic candidate for lung cancer: Emerging preclinical evidence |
- | Review, | Var, | NA |
2921- | LT, | Luteolin as a potential hepatoprotective drug: Molecular mechanisms and treatment strategies |
- | Review, | Nor, | NA |
2927- | LT, | Luteolin Causes 5′CpG Demethylation of the Promoters of TSGs and Modulates the Aberrant Histone Modifications, Restoring the Expression of TSGs in Human Cancer Cells |
- | in-vitro, | Cerv, | HeLa |
2914- | LT, | Therapeutic Potential of Luteolin on Cancer |
- | Review, | Var, | NA |
2907- | LT, | Protective effect of luteolin against oxidative stress‑mediated cell injury via enhancing antioxidant systems |
- | in-vitro, | Nor, | NA |
2589- | LT, | Chemo, | Luteolin Inhibits Breast Cancer Stemness and Enhances Chemosensitivity through the Nrf2-Mediated Pathway |
- | in-vitro, | BC, | MDA-MB-231 |
2588- | LT, | Chemo, | Luteolin sensitizes two oxaliplatin-resistant colorectal cancer cell lines to chemotherapeutic drugs via inhibition of the Nrf2 pathway |
- | in-vitro, | CRC, | HCT116 |
2587- | LT, | Luteolin inhibits Nrf2 leading to negative regulation of the Nrf2/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugs |
- | in-vitro, | Lung, | A549 |
4292- | LT, | Luteolin for neurodegenerative diseases: a review |
- | Review, | AD, | NA | - | Review, | Park, | NA | - | Review, | MS, | NA | - | Review, | Stroke, | NA |
3528- | Lyco, | The Importance of Antioxidant Activity for the Health-Promoting Effect of Lycopene |
- | Review, | Nor, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
3531- | Lyco, | Lycopene attenuates the inflammation and apoptosis in aristolochic acid nephropathy by targeting the Nrf2 antioxidant system |
- | in-vivo, | Nor, | NA |
3268- | Lyco, | Lycopene as a Natural Antioxidant Used to Prevent Human Health Disorders |
- | Review, | AD, | NA |
3264- | Lyco, | Pharmacological potentials of lycopene against aging and aging‐related disorders: A review |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Stroke, | NA |
4230- | Lyco, | Supplementation of lycopene attenuates oxidative stress induced neuroinflammation and cognitive impairment via Nrf2/NF-κB transcriptional pathway |
- | in-vivo, | AD, | NA |
1708- | Lyco, | The Anti-Cancer Activity of Lycopene: A Systematic Review of Human and Animal Studies |
- | Review, | Var, | NA |
1780- | MEL, | Utilizing Melatonin to Alleviate Side Effects of Chemotherapy: A Potentially Good Partner for Treating Cancer with Ageing |
- | Review, | Var, | NA |
1204- | MET, | Metformin induces ferroptosis through the Nrf2/HO-1 signaling in lung cancer |
- | in-vitro, | Lung, | A549 | - | in-vitro, | Lung, | H1299 |
3468- | MF, | An integrative review of pulsed electromagnetic field therapy (PEMF) and wound healing |
- | Review, | NA, | NA |
3848- | MSM, | Modulatory effect of methylsulfonylmethane against BPA/γ-radiation induced neurodegenerative alterations in rats: Influence of TREM-2/DAP-12/Syk pathway |
- | in-vitro, | AD, | NA |
2932- | NAD, | Neuroprotective effects and mechanisms of action of nicotinamide mononucleotide (NMN) in a photoreceptor degenerative model of retinal detachment |
- | in-vitro, | Nor, | NA |
1680- | PBG, | Protection against Ultraviolet A-Induced Skin Apoptosis and Carcinogenesis through the Oxidative Stress Reduction Effects of N-(4-bromophenethyl) Caffeamide, a Propolis Derivative |
- | in-vitro, | Nor, | HS68 |
3250- | PBG, | Allergic Inflammation: Effect of Propolis and Its Flavonoids |
- | Review, | NA, | NA |
3251- | PBG, | The Antioxidant and Anti-Inflammatory Effects of Flavonoids from Propolis via Nrf2 and NF-κB Pathways |
- | Review, | AD, | NA | - | Review, | Diabetic, | NA | - | Review, | Var, | NA | - | in-vitro, | Nor, | H9c2 |
3252- | PBG, | Propolis Extract and Its Bioactive Compounds—From Traditional to Modern Extraction Technologies |
- | Review, | NA, | NA |
3254- | PBG, | Brazilian green propolis water extract up-regulates the early expression level of HO-1 and accelerates Nrf2 after UVA irradiation |
- | in-vitro, | Nor, | NA |
1770- | PG, | Propyl gallate sensitizes human lung cancer cells to cisplatin-induced apoptosis by targeting heme oxygenase-1 for TRC8-mediated degradation |
- | in-vitro, | Lung, | NA |
4220- | PI, | Piperine ameliorated memory impairment and myelin damage in lysolecethin induced hippocampal demyelination |
- | in-vivo, | AD, | NA | - | in-vivo, | MS, | NA |
2955- | PL, | Heme Oxygenase-1 Determines the Differential Response of Breast Cancer and Normal Cells to Piperlongumine |
- | in-vitro, | BC, | MCF-7 | - | in-vitro, | Nor, | MCF10 |
2954- | PL, | The metabolites from traditional Chinese medicine targeting ferroptosis for cancer therapy |
- | Review, | Var, | NA |
2948- | PL, | The promising potential of piperlongumine as an emerging therapeutics for cancer |
- | Review, | Var, | NA |
2946- | PL, | Piperlongumine, a potent anticancer phytotherapeutic: Perspectives on contemporary status and future possibilities as an anticancer agent |
- | Review, | Var, | NA |
3929- | PTS, | New Insights into Dietary Pterostilbene: Sources, Metabolism, and Health Promotion Effects |
- | Review, | Var, | NA | - | Review, | Arthritis, | NA |
3924- | PTS, | Effect of resveratrol and pterostilbene on aging and longevity |
- | Review, | AD, | NA | - | Review, | Stroke, | NA |
2338- | QC, | Quercetin: A Flavonoid with Potential for Treating Acute Lung Injury |
- | Review, | Nor, | NA |
3350- | QC, | Quercetin and the mitochondria: A mechanistic view |
- | Review, | NA, | NA |
3347- | QC, | Recent Advances in Potential Health Benefits of Quercetin |
- | Review, | Var, | NA | - | Review, | AD, | NA |
3346- | QC, | Regulation of the Intracellular ROS Level Is Critical for the Antiproliferative Effect of Quercetin in the Hepatocellular Carcinoma Cell Line HepG2 |
- | in-vitro, | Liver, | HepG2 | - | in-vitro, | Liver, | HUH7 |
3343- | QC, | Quercetin, a Flavonoid with Great Pharmacological Capacity |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Arthritis, | NA |
3341- | QC, | Antioxidant Activities of Quercetin and Its Complexes for Medicinal Application |
- | Review, | Var, | NA | - | Review, | Stroke, | NA |
39- | QC, | A Comprehensive Analysis and Anti-Cancer Activities of Quercetin in ROS-Mediated Cancer and Cancer Stem Cells |
- | Analysis, | NA, | NA |
923- | QC, | Quercetin as an innovative therapeutic tool for cancer chemoprevention: Molecular mechanisms and implications in human health |
- | Review, | Var, | NA |
2441- | RES, | Anti-Cancer Properties of Resveratrol: A Focus on Its Impact on Mitochondrial Functions |
- | Review, | Var, | NA |
2566- | RES, | A comprehensive review on the neuroprotective potential of resveratrol in ischemic stroke |
- | Review, | Stroke, | NA |
3077- | RES, | Resveratrol attenuates matrix metalloproteinase-9 and -2-regulated differentiation of HTB94 chondrosarcoma cells through the p38 kinase and JNK pathways |
- | in-vitro, | Chon, | HTB94 |
3062- | RES, | Resveratrol enhances post-injury muscle regeneration by regulating antioxidant and mitochondrial biogenesis |
- | in-vivo, | Nor, | NA |
3061- | RES, | The Anticancer Effects of Resveratrol: Modulation of Transcription Factors |
- | Review, | Var, | NA |
3059- | RES, | Resveratrol, an Nrf2 activator, ameliorates aging-related progressive renal injury |
- | in-vivo, | Nor, | HK-2 |
3057- | RES, | The therapeutic effect of resveratrol: Focusing on the Nrf2 signaling pathway |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Stroke, | NA |
3100- | RES, | Neuroprotective effects of resveratrol in Alzheimer disease pathology |
- | Review, | AD, | NA |
3099- | RES, | Resveratrol and cognitive decline: a clinician perspective |
- | Review, | Nor, | NA | - | NA, | AD, | NA |
3092- | RES, | Resveratrol in breast cancer treatment: from cellular effects to molecular mechanisms of action |
- | Review, | BC, | MDA-MB-231 | - | Review, | BC, | MCF-7 |
3612- | RES, | Resveratrol in Alzheimer's disease: a review of pathophysiology and therapeutic potential |
- | Review, | AD, | NA |
4286- | RES, | Neuroprotective Properties of Resveratrol and Its Derivatives—Influence on Potential Mechanisms Leading to the Development of Alzheimer’s Disease |
- | Review, | AD, | NA |
3615- | RosA, | Potential Therapeutic Use of the Rosemary Diterpene Carnosic Acid for Alzheimer's Disease, Parkinson's Disease, and Long-COVID through NRF2 Activation to Counteract the NLRP3 Inflammasome |
- | Review, | AD, | NA | - | Review, | Park, | NA |
1744- | RosA, | Therapeutic Applications of Rosmarinic Acid in Cancer-Chemotherapy-Associated Resistance and Toxicity |
- | Review, | Var, | NA |
3001- | RosA, | Therapeutic Potential of Rosmarinic Acid: A Comprehensive Review |
- | Review, | Var, | NA |
3002- | RosA, | Anticancer Effects of Rosemary (Rosmarinus officinalis L.) Extract and Rosemary Extract Polyphenols |
- | Review, | Var, | NA |
1090- | SANG, | Sanguinarine inhibits invasiveness and the MMP-9 and COX-2 expression in TPA-induced breast cancer cells by inducing HO-1 expression. |
- | in-vitro, | BC, | MCF-7 |
4190- | Sesame, | Sesame Seeds: A Nutrient-Rich Superfood |
- | Review, | NA, | NA |
4199- | SFN, | Sulforaphane and Brain Health: From Pathways of Action to Effects on Specific Disorders |
- | Review, | AD, | NA | - | Review, | Park, | NA |
3663- | SFN, | Efficacy of Sulforaphane in Neurodegenerative Diseases |
- | Review, | AD, | NA | - | Review, | Park, | NA |
3657- | SFN, | Sulforaphane exerts its anti-inflammatory effect against amyloid-β peptide via STAT-1 dephosphorylation and activation of Nrf2/HO-1 cascade in human THP-1 macrophages |
- | NA, | AD, | THP1 |
3658- | SFN, | Pre-Clinical Neuroprotective Evidences and Plausible Mechanisms of Sulforaphane in Alzheimer’s Disease |
- | Review, | AD, | NA |
3660- | SFN, | Sulforaphane - role in aging and neurodegeneration |
- | Review, | AD, | NA |
1722- | SFN, | Sulforaphane as an anticancer molecule: mechanisms of action, synergistic effects, enhancement of drug safety, and delivery systems |
- | Review, | Var, | NA |
1726- | SFN, | Sulforaphane: A Broccoli Bioactive Phytocompound with Cancer Preventive Potential |
- | Review, | Var, | NA |
- | in-vitro, | Bladder, | T24 |
1429- | SFN, | Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast |
- | in-vivo, | Nor, | NA | - | Human, | Nor, | NA |
1437- | SFN, | Dietary Sulforaphane in Cancer Chemoprevention: The Role of Epigenetic Regulation and HDAC Inhibition |
- | Review, | NA, | NA |
1431- | SFN, | Induction of the phase 2 response in mouse and human skin by sulforaphane-containing broccoli sprout extracts |
- | in-vivo, | Nor, | NA |
2552- | SFN, | Chemo, | Chemopreventive activity of sulforaphane |
- | Review, | Var, | NA |
2553- | SFN, | Mechanistic review of sulforaphane as a chemoprotective agent in bladder cancer |
- | Review, | Bladder, | NA |
3192- | SFN, | Transcriptome analysis reveals a dynamic and differential transcriptional response to sulforaphane in normal and prostate cancer cells and suggests a role for Sp1 in chemoprevention |
- | in-vitro, | Pca, | PC3 |
3184- | SFN, | The Integrative Role of Sulforaphane in Preventing Inflammation, Oxidative Stress and Fatigue: A Review of a Potential Protective Phytochemical |
- | Review, | Nor, | NA |
3302- | SIL, | Protective effects of silymarin in glioblastoma cancer cells through redox system regulation |
- | in-vitro, | GBM, | U87MG |
3307- | SIL, | Flavolignans from Silymarin as Nrf2 Bioactivators and Their Therapeutic Applications |
- | Review, | Var, | NA |
3310- | SIL, | Silymarin attenuates paraquat-induced lung injury via Nrf2-mediated pathway in vivo and in vitro |
- | in-vitro, | Lung, | A549 |
3315- | SIL, | Silymarin alleviates docetaxel-induced central and peripheral neurotoxicity by reducing oxidative stress, inflammation and apoptosis in rats |
- | in-vivo, | Nor, | NA |
3324- | SIL, | Silymarin prevents NLRP3 inflammasome activation and protects against intracerebral hemorrhage |
3319- | SIL, | Silymarin and neurodegenerative diseases: Therapeutic potential and basic molecular mechanisms |
- | Review, | AD, | NA | - | Review, | Park, | NA | - | Review, | Stroke, | NA |
3318- | SIL, | Pharmaceutical prospects of Silymarin for the treatment of neurological patients: an updated insight |
- | Review, | AD, | NA | - | Review, | Park, | NA |
3316- | SIL, | Chemo, | Silymarin Nanoparticles Counteract Cognitive Impairment Induced by Doxorubicin and Cyclophosphamide in Rats; Insights into Mitochondrial Dysfunction and Nrf2/HO-1 Axis |
3313- | SIL, | Silymarin attenuates post-weaning bisphenol A-induced renal injury by suppressing ferroptosis and amyloidosis through Kim-1/Nrf2/HO-1 signaling modulation in male Wistar rats |
- | in-vivo, | NA, | NA |
2217- | SK, | Shikonin Inhibits Endoplasmic Reticulum Stress-Induced Apoptosis to Attenuate Renal Ischemia/Reperfusion Injury by Activating the Sirt1/Nrf2/HO-1 Pathway |
- | in-vivo, | Nor, | NA | - | in-vitro, | Nor, | HK-2 |
2220- | SK, | Shikonin Alleviates Gentamicin-Induced Renal Injury in Rats by Targeting Renal Endocytosis, SIRT1/Nrf2/HO-1, TLR-4/NF-κB/MAPK, and PI3K/Akt Cascades |
- | in-vivo, | Nor, | NA |
2218- | SK, | Shikonin Alleviates Endothelial Cell Injury Induced by ox-LDL via AMPK/Nrf2/HO-1 Signaling Pathway |
- | in-vitro, | Nor, | HUVECs |
3042- | SK, | The protective effects of Shikonin on lipopolysaccharide/D -galactosamine-induced acute liver injury via inhibiting MAPK and NF-kB and activating Nrf2/HO-1 signaling pathways |
- | in-vivo, | Nor, | NA |
1346- | SK, | An Oxidative Stress Mechanism of Shikonin in Human Glioma Cells |
- | in-vitro, | GBM, | U87MG | - | in-vitro, | GBM, | Hs683 |
2201- | SK, | Shikonin promotes ferroptosis in HaCaT cells through Nrf2 and alleviates imiquimod-induced psoriasis in mice |
- | in-vitro, | PSA, | HaCaT | - | in-vivo, | NA, | NA |
2214- | SK, | Shikonin Attenuates Cochlear Spiral Ganglion Neuron Degeneration by Activating Nrf2-ARE Signaling Pathway |
- | in-vitro, | Nor, | NA |
2196- | SK, | Research progress in mechanism of anticancer action of shikonin targeting reactive oxygen species |
- | Review, | Var, | NA |
2195- | SK, | Shikonin induces ferroptosis in osteosarcomas through the mitochondrial ROS-regulated HIF-1α/HO-1 axis |
- | in-vitro, | OS, | NA |
3960- | Taur, | Versatile Triad Alliance: Bile Acid, Taurine and Microbiota |
- | Review, | AD, | NA | - | Review, | Stroke, | NA |
3420- | TQ, | Thymoquinone alleviates the accumulation of ROS and pyroptosis and promotes perforator skin flap survival through SIRT1/NF-κB pathway |
- | in-vitro, | Nor, | HUVECs | - | in-vitro, | NA, | NA |
3398- | TQ, | 5-FU, | Impact of thymoquinone on the Nrf2/HO-1 and MAPK/NF-κB axis in mitigating 5-fluorouracil-induced acute kidney injury in vivo |
- | in-vivo, | Nor, | NA |
3402- | TQ, | Enhanced Apoptosis in Pancreatic Cancer Cells through Thymoquinone-rich Nigella sativa L. Methanol Extract: Targeting NRF2/HO-1 and TNF-α Pathways |
- | in-vitro, | PC, | PANC1 | - | in-vitro, | PC, | MIA PaCa-2 |
3405- | TQ, | doxoR, | Protective effect of thymoquinone against doxorubicin-induced cardiotoxicity and the underlying mechanism |
- | vitro+vivo, | NA, | NA |
3410- | TQ, | Anti-inflammatory effects of thymoquinone and its protective effects against several diseases |
- | Review, | Arthritis, | NA |
1935- | TQ, | Potential anticancer properties and mechanisms of thymoquinone in osteosarcoma and bone metastasis |
- | Review, | OS, | NA |
2130- | TQ, | Thymoquinone Attenuates Brain Injury via an Anti-oxidative Pathway in a Status Epilepticus Rat Model |
- | in-vivo, | Nor, | NA |
2131- | TQ, | Therapeutic impact of thymoquninone to alleviate ischemic brain injury via Nrf2/HO-1 pathway |
- | in-vitro, | Stroke, | NA | - | in-vivo, | Nor, | NA |
2132- | TQ, | Thymoquinone treatment modulates the Nrf2/HO-1 signaling pathway and abrogates the inflammatory response in an animal model of lung fibrosis |
- | in-vivo, | Nor, | NA |
2133- | TQ, | CUR, | Cisplatin, | Thymoquinone and curcumin combination protects cisplatin-induced kidney injury, nephrotoxicity by attenuating NFκB, KIM-1 and ameliorating Nrf2/HO-1 signalling |
- | in-vitro, | Nor, | HEK293 | - | in-vivo, | NA, | NA |
2134- | TQ, | Modulation of Nrf2/HO1 Pathway by Thymoquinone to Exert Protection Against Diazinon-induced Myocardial Infarction in Rats |
- | in-vivo, | Nor, | NA |
2135- | TQ, | Thymoquinone induces heme oxygenase-1 expression in HaCaT cells via Nrf2/ARE activation: Akt and AMPKα as upstream targets |
- | in-vitro, | Nor, | HaCaT |
2128- | TQ, | Thymoquinone inhibits phorbol ester-induced activation of NF-κB and expression of COX-2, and induces expression of cytoprotective enzymes in mouse skin in vivo |
- | in-vivo, | NA, | NA |
2106- | TQ, | Cancer: Thymoquinone antioxidant/pro-oxidant effect as potential anticancer remedy |
- | Review, | Var, | NA |
3109- | VitC, | Vitamin C Inhibited Pulmonary Metastasis through Activating Nrf2/HO-1 Pathway |
- | in-vitro, | Lung, | H1299 |
3108- | VitC, | QC, | The role of quercetin and vitamin C in Nrf2-dependent oxidative stress production in breast cancer cells |
- | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | Lung, | A549 |
2276- | VitK2, | Vitamin K2 (MK-7) Intercepts Keap-1/Nrf-2/HO-1 Pathway and Hinders Inflammatory/Apoptotic Signaling and Liver Aging in Naturally Aging Rat |
- | in-vivo, | Nor, | NA |
2275- | VitK2, | Delivery of the reduced form of vitamin K2(20) to NIH/3T3 cells partially protects against rotenone induced cell death |
- | in-vitro, | Nor, | NIH-3T3 |
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:597 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid